gracecastuc-076_lung_utility of molecular marker results in adjuvant setting for early stage nsclc
Published 11 years ago • 14 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
1:23
gracecastuc-067_lung_dr. goldberg on utility of molecular marker results in the adjuvant setting
-
1:59
gracecastuc-026_lung_dr. wakelee on using molecular marker info for mgmt. of earlier stage nsclc
-
2:11
gracecastuc-039_lung_how i use molecular marker information in earlier stage nsclc patients
-
1:38
gracecastuc-049_lung_seek and use molecular marker information in patients with early stage nsclc?
-
16:39
gracecast-067_lung-cancer_expert round table - nsclc molecular markers case 3
-
2:32
segmentectomy for early stage nsclc - onctalk lung 2023
-
2:58
gracecastuc-068_lung_dr. oxnard on what molecular markers to test for in advanced nsclc
-
5:39
gracecastuc 127 lung_molecular markers predicting the best chemotherapy to use in lung cancer
-
1:10
gracecastuc-070_lung_dr. reckamp on "which patients do you test for molecular marker, and for what?"
-
2:11
gracecastuc-027_lung_dr. kelly - what molecular markers to send in for adv. nsclc patients?
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
4:57
q&a: is biomarker testing common in early stage nsclc? - targeted therapies in lung cancer 2023
-
2:53
lobectomy for early stage nsclc - onctalk lung 2023
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
2:18
gracecastuc-045_lung_which lung cancer patients should we be doing molecular marker testing for?
-
19:30
gracecast152_lung_dr. kratz_pt3_evidence for biology based staging
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
5:42
gracecastuc-006 - which patients with advanced lung cancer should potentially receive local therapy?
-
1:22
gracecastuc-066_lung_dr. lecia sequist on relevant emerging molecular targets in lung cancer